Target Name: TENT5C
NCBI ID: G54855
Review Report on TENT5C Target / Biomarker Content of Review Report on TENT5C Target / Biomarker
TENT5C
Other Name(s): FAM46C | Protein FAM46C | protein FAM46C | putative nucleotidyltransferase FAM46C | TET5C_HUMAN | FLJ20202 | OTTHUMP00000015538 | Terminal nucleotidyltransferase 5C | terminal nucleotidyltransferase 5C | family with sequence similarity 46 member C | non-canonical poly(A) polymerase FAM46C | FA46C_HUMAN | Non-canonical poly(A) polymerase FAM46C

TENT5C: A Drug Target / Disease Biomarker

TENT5C, also known as T cell-derived neurotrophic factor (TNT), is a protein that is produced by T cells, which are a type of immune cell in the body. T cells are important for helping the body to fight off infections and diseases, but they can also cause problems if they become overactive or if they are not functioning properly.

TENT5C is a signaling molecule that helps T cells to communicate with each other and to control their activity. It is produced by T cells that have been activated by an antigen, which is a molecule that the body recognizes as foreign or dangerous. When an antigen is present, T cells become activated and begin to divide and differentiate into different types of immune cells.

TENT5C is important for helping T cells to recognize and respond to antigens. It helps the cells to communicate with each other and to coordinate their actions. It also helps the cells to determine when to stop dividing and to start producing antibodies, which are proteins that help the body to fight off infections.

Research has suggested that TENT5C may have potential as a drug target or biomarker. For example, some studies have suggested that TENT5C may be a good candidate for treatment for certain types of cancer, because it can help T cells to recognize and respond to cancer cells. Other studies have suggested that TENT5C may be a good candidate for use as a biomarker for certain types of diseases, because it can be produced by the body and can be used as a diagnostic tool.

TENT5C is also of interest to researchers because of its unique structure and biology. Unlike many other proteins, which are made up of a series of amino acids, TENT5C is made up of a single protein that is encoded by a single gene. This makes it relatively easy to study and to understand its biology.

In addition, TENT5C is also a good candidate for use as a potential vaccine. Because it is produced by the body, it is not like many other proteins, which are often made artificially in a laboratory. This makes it a more natural and effective source of a vaccine.

Overall, TENT5C is a protein that is produced by T cells and has the potential to be a drug target or biomarker. Further research is needed to fully understand its biology and its potential uses.

Protein Name: Terminal Nucleotidyltransferase 5C

Functions: Catalyzes the transfer of one adenosine molecule from an ATP to an mRNA poly(A) tail bearing a 3'-OH terminal group and enhances mRNA stability and gene expression (PubMed:32009146, PubMed:28931820, PubMed:34048638). Can also elongate RNA oligos ending with uridine molecule, provided that the sequence is adenosine-rich (PubMed:34048638). Mainly targets mRNAs encoding endoplasmic reticulum-targeted protein (PubMed:28931820)

The "TENT5C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TENT5C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TENT5C-DT | TENT5D | TEP1 | TEPP | TEPSIN | TERB1 | TERB2 | TERC | TERF1 | TERF1P3 | TERF2 | TERF2IP | TERLR1 | TERT | TES | TESC | TESK1 | TESK2 | TESMIN | TESPA1 | TET1 | TET2 | TET2-AS1 | TET3 | Tetraspanin | TEX10 | TEX101 | TEX11 | TEX12 | TEX13A | TEX13B | TEX13C | TEX14 | TEX15 | TEX19 | TEX2 | TEX21P | TEX22 | TEX26 | TEX261 | TEX264 | TEX28 | TEX29 | TEX30 | TEX33 | TEX35 | TEX36 | TEX36-AS1 | TEX37 | TEX38 | TEX41 | TEX43 | TEX44 | TEX45 | TEX46 | TEX47 | TEX48 | TEX49 | TEX50 | TEX52 | TEX53 | TEX55 | TEX56P | TEX9 | TF | TFAM | TFAMP1 | TFAP2A | TFAP2A-AS1 | TFAP2A-AS2 | TFAP2B | TFAP2C | TFAP2D | TFAP2E | TFAP4 | TFB1M | TFB2M | TFCP2 | TFCP2L1 | TFDP1 | TFDP1P2 | TFDP2 | TFDP3 | TFE3 | TFEB | TFEC | TFF1 | TFF2 | TFF3 | TFG | TFIID Basal Transcription Factor Complex | TFIIIC2 complex | TFIP11 | TFIP11-DT | TFPI | TFPI2 | TFPT | TFR2 | TFRC | TG